Influence of an inducible nitric oxide synthase promoter variant on clinical variables in patients with coronary artery disease

Clinical Science

Volumn 100, Issue 5, 2001, Pages 551-556

  Morris, Brian J ^a   Glenn, Cheryl L ^a   Wilcken, David E L ^b   Wang, Xing Li ^b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Angina; Coronary artery disease; Nitric oxide synthase; Plasma glucose

Indexed keywords

DNA; GLUCOSE; NITRIC OXIDE SYNTHASE;

ADULT; ALLELE; ANGINA PECTORIS; ANGIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; ALLELES; ANGINA PECTORIS; ANGINA, UNSTABLE; BLOOD GLUCOSE; BODY CONSTITUTION; CORONARY DISEASE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; PROMOTER REGIONS (GENETICS); SEX FACTORS;

EID: 0035038370     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20000223     Document Type: Article

References (29)

1. 1 Noiri, E., Peresieni, T., Miller, F. and Goligorsky, M. S. (1996) In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J. Clin. Invest. 97, 2377-2383
2. 2 Mayer, B. and Hemmens, B. (1997) Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem. Sci. 22, 477-481
3. 3 Nathan, C. (1997) Inducible nitric oxide synthase: What difference does it make? J. Clin. Invest. 100, 2417-2423
4. 4 Kröncke, K.-D., Fehsel, K. and Kolb-Bachofen, V. (1998) Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol. 113, 147-156
5. 5 Mattson, D. L., Maeda, C. Y., Bachman, T. D. and Cowley, A. W. (1998) Inducible nitric oxide synthase and blood pressure. Hypertension 31, 15-20
6. 6 Buttery, L. D. K., Springall, D. R., Chester, A. H. et al. (1996) Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab. Invest. 75, 77-85
7. 7 Ravalli, S., Albala, A., Ming, M. et al. (1998) Inducible nitric oxide synthase expression in smooth muscle cells and macrophages of human transplant coronary artery disease. Circulation 97, 2338-2345
8. 8 Kim, Y. M., de Vera, M. E., Watkins, S. C. and Billiar, T. R. (1997) Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem. 272, 1402-1411
9. 9 Bellamy, R. and Hill, A. V. S. (1997) A bi-allelic tetranucleotide repeat in the promoter of the human inducible nitric oxide synthase gene. Clin. Genet. 52, 192-193
10. 10 Nunokawa, Y., Ishida, N. and Tanaka, S. (1994) Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis. Biochem. Biophys. Res. Commun. 200, 802-807
11. 11 Cambien, F., Poirier, O., Nicaud, V. et al. (1999) Sequence diversity in 36 candidate genes for cardiovascular disorders. Am. J. Hum. Genet. 65, 183-191
12. 12 Morris, B. J., Glenn, C. L., Markus, M. A., Adams, D. J., Colagiuri, S. and Wang, X. L. (2000) Genetic basis of diabetic nephropathy: Role of iNOS promoter polymorphism. 11th Int. Congr. Endocrinol., Sydney, 29 October-2 November 2000, p. 48 (abstract)
13. 13 Glenn, C. L., Wang, W. Y. S. and Morris, B. J. (1999) Different frequencies of inducible nitric oxide synthase genotypes in older hypertensives. Hypertension 33, 927-932
14. 14 Warpeha, K. M., Xu, W., Liu, L. et al. (1999) Genotyping and functional analysis of a polymorphic (CCTTT)n repeat of NOS2A in diabetic nephropathy. FASEB J. 13, 1825-1832
15. 15 Johannsen, J., Tarnow, L., Parving, H.-H., Nerup, J. and Pociot, F. (2000) CCTTT-repeat polymorphism in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients. Diabetes Care 23, 560-562
16. 16 Rikitake, Y., Hirata, K., Kawashima, S., Akita, H. and Yokoyama, M. (1998) Inhibitory effect of inducible nitric oxide synthase on oxidative modification of low density lipoprotein by vascular smooth muscle cells. Atherosclerosis 136, 51-57
17. 17 Behr-Roussel, D., Rupin, A., Sansilvestri-Morel, P., Fabiani, J. N. and Verbeuren, T. J. (2000) Histochemical evidence for inducible nitric oxide synthase in advanced but non-ruptured atherosclerotic carotid arteries. Histochem. J. 32, 41-51
18. 18 Alfon, J., Guasch, J. F., Berrozpe, M. and Badimon, L. (1999) Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventative effects of HMG-CoA reductase inhibitors. Atherosclerosis 145, 325-331
19. 19 Wang, X. L., Sim, A. S., Badenhop, R., McCredie, M. R. and Wilcken, D. E. L. (1996) A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat. Med. (N. Y.) 2, 41-45
20. 20 Khoury, M. J., Beaty, T. H. and Cohen, B. H. (1993) Fundamentals of Genetic Epidemiology. Monographs in Epidemiology and Biostatistics (Kelsey, J. L., Marmot, M. G., Stolley, P. D. and Vessey, M. P., eds), vol. 19, Oxford University Press, New York
21. 21 McNeil, D. (1995) Power of a study. In Epidemiological Research Methods, pp. 271-279, John Wiley & Sons, New York
22. 22 Schmidt, M. I., Duncan, B. B., Sharrett, A. R. et al. (1999) Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353, 1649-1652
23. 23 Yan, Z. and Hansson, G. K. (1998) Overexpression of inducible nitric oxide synthase by neointimal smooth muscle. Circ. Res. 82, 21-29
24. 24 Kun, J. F. J., Mordmüller, B., Lell, B., Lehman, L. G., Luckner, D. and Kremsner, P. G. (1998) Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 351, 265-266
25. 25 Engeli, S., Janke, J., Kettler, M., Gorzelniak, K. and Sharma, A. M. (2000) Nitric oxide system genes and formation of nitric oxide in human adipose tissue. Int. J. Obesity 24 (Suppl. 1), S28 (abstract 72)
26. 26 Marette, A. and Perreault, M. (2000) Genetic ablation of iNOS gene improves insulin sensitivity in high-fat fed obese mice. Int. J. Obesity 24 (Suppl. 1), S12 (abstract 26)
27. 27 Picard, F., Lalonde, J., Perreault, M., Marette, A. and Deshaies, Y. (2000) Nitric oxide mediates the elevation of plasma leptin levels during endotoxemia. Int. J. Obesity 24 (Suppl. 1), S134 (abstract 440)
28. 28 Kersten, S., Desvergne, B. and Wahli, W. (2000) Roles of PPARs in health and disease. Nature (London) 405, 421-424
29. 29 Melander, O., Groop, L. and Hulthén, U. L. (2000) Effect of salt on insulin sensitivity differs according to gender and degree of salt sensitivity. Hypertension 35, 827-831